Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

NEURONES: 2012 annual results


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-02-27 17:44:27 -

PRESS INFORMATION                        Nanterre, February 27, 2013
(after the
closing of the stock exchange)
Heading: 2012 annual results



                           8.9% operating profit and
                        €17.2 million net profit in 2012



-------------------------------------+---------------+---------------
  Accounts as at 31 December         |          2012 |          2011
  (audited and in millions of euros) |               |
-------------------------------------+---------------+---------------
  Revenues 
| 315.4 | 283.3 -------------------------------------+---------------+--------------- Business operating profit * |   29.2 (9.3%) |   27.1 (9.6%) -------------------------------------+---------------+--------------- Operating profit |   28.1 (8.9%) |   26.3 (9.3%) -------------------------------------+---------------+--------------- Net financial profit |     1.4 |     2.5 -------------------------------------+---------------+--------------- Income tax |  (12.3) |  (11.8) -------------------------------------+---------------+--------------- Net profit |   17.2 (5.4%) |   17.0 (6.0%) -------------------------------------+---------------+--------------- * of which, group share |   14.9 |   14.8 -------------------------------------+---------------+--------------- Net cash and cash equivalents |   87.8 |   75.1 -------------------------------------+---------------+--------------- Staff at year-end | 3,704 | 3,471 -------------------------------------+---------------+--------------- (*) Prior to cost of free shares, stock options and impairment of assets Achievements In a steady market, NEURONES experienced growth of 11.3% in 2012 (including 9.3% internal growth). Operating profit (*) in 2012 also increased and totaled 8.9% of revenues. The net profit after tax (rate of 41.7%, including CVAE, a contribution based on businesses' added value) amounted to 5.4%. The conversion of net profit into cash was satisfactory. The net cash and cash equivalents at year-end stood at €87.8 million (i.e. €3.71 per share). Goodwill only represents three years of the acquired companies' cash flow overall. (*) after 0.4% related to the cost of free shares, stock options and impairment of assets. Outlook As usual, forecasts for the current year will be posted along with the Group's 1(st) quarter revenues. About NEURONES With over 3,700 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems. The size of the group has doubled over the past five years. NYSE Euronext: Compartment B - ISIN code: FR0004050250 - NYSE symbol: NRO www.neurones.net Press Relations:   Investor relations: Florence Gillier NEURONES NEURONES Communication Matthieu Vautier Paul-César Bonnel Frédérique Guillo Tel.: +33 (0)1 41 37 41 37 Tel.: +33 (0)1 41 37 41 37 Tel.: +33 (0)1 41 18 85 55 rp@neurones.net investisseurs@neurones.net fredg@fgcom.fr NEURONES - 2012 annual results: hugin.info/143513/R/1681718/549862.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: NEURONES via Thomson Reuters ONE [HUG#1681718]


Press Information:




Contact Person:


Disclaimer: © 2013 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser